Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 6
Submit an article Journal homepage
113
Views
18
CrossRef citations to date
0
Altmetric
Original

New anti-CD30 human pancreatic ribonuclease-based immunotoxin reveals strong and specific cytotoxicity in vivo

Sandra Braschoss Institut für Pathologie, Charité-Campus Benjamin Franklin (FU Berlin)Germany
,
Burkhard Hirsch Institut für Pathologie, Charité-Campus Benjamin Franklin (FU Berlin)Germany
,
Stefan Dübel Institut für Biochemie und Biotechnologie, TU BraunschweigGermany
,
Harald Stein Institut für Pathologie, Charité-Campus Benjamin Franklin (FU Berlin)Germany
&
Horst Dürkop MD Institut für Pathologie, Charité-Campus Benjamin Franklin (FU Berlin)GermanyCorrespondence[email protected]
Pages 1179-1186 | Received 20 Sep 2006, Accepted 09 Feb 2007, Published online: 01 Jul 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Thomas Schirrmann, Jürgen Krauss, Michaela AE Arndt, Susanna M Rybak & Stefan Dübel. (2009) Targeted therapeutic RNases (ImmunoRNases). Expert Opinion on Biological Therapy 9:1, pages 79-95.
Read now
Hinrich P Hansen & Andreas Engert. (2008) Treatment of CD30-positive diseases, such as Hodgkin's lymphoma, by administration of a combination of sheddase inhibitor and anti-CD30 immunotherapeutic agents. Expert Opinion on Therapeutic Patents 18:6, pages 671-676.
Read now
John C. Morris$suffix/text()$suffix/text() & John E. Janik. (2007) Therapeutic immunotoxins for lymphoid malignancies: The end of the beginning. Leukemia & Lymphoma 48:6, pages 1067-1069.
Read now

Articles from other publishers (15)

Maryam Dashtiahangar, Leila Rahbarnia, Safar Farajnia, Arash Salmaninejad, Arezoo Gowhari Shabgah & Samaneh Ghasemali. (2021) Anti-cancer Immunotoxins, Challenges, and Approaches. Current Pharmaceutical Design 27:7, pages 932-941.
Crossref
Zhengqiu Zhou, Grant L. Austin, Robert Shaffer, Dustin D. Armstrong & Matthew S. Gentry. (2019) Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases. Trends in Molecular Medicine 25:12, pages 1094-1109.
Crossref
Xenia Wezler, Stefan Dübel & Thomas Schirrmann. (2018) Antibody fusion proteins with human ribonucleases 1 to 8. Human Antibodies 26:4, pages 177-192.
Crossref
Yehudit Grinberg & Itai Benhar. (2017) Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins. Biomedicines 5:4, pages 28.
Crossref
Athanasios Mavratzas, Michaela A.E. Arndt, Stefan Kiesgen & Jürgen Krauss. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 363 390 .
Ines Höfig, Stefan Barth, M. Salomon, Verena Jagusch, Mike J. Atkinson, Natasa Anastasov & Christian Thirion. (2014) Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein. Biomaterials 35:13, pages 4204-4212.
Crossref
Thomas Schirrmann, Miriam Steinwand, Xenia Wezler, Andre ten Haaf, Mehmet K. Tur & Stefan Barth. (2013) CD30 as a Therapeutic Target for Lymphoma. BioDrugs 28:2, pages 181-209.
Crossref
Wojciech Ardelt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals 337 353 .
Fang Wu, Hong Ding & Zhirong Zhang. 2012. Antibody‐Mediated Drug Delivery Systems. Antibody‐Mediated Drug Delivery Systems 169 190 .
Hendrik Fuchs & Christopher Bachran. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 1443 1487 .
Carima Andrady, Surinder K Sharma & Kerry A Chester. (2011) Antibody–enzyme fusion proteins for cancer therapy. Immunotherapy 3:2, pages 193-211.
Crossref
Marc Ribó, Antoni Benito & Maria Vilanova. 2011. Ribonucleases. Ribonucleases 55 88 .
Claudia De Lorenzo & Giuseppe D’Alessio. (2009) Human anti‐ErbB2 immunoagents – immunoRNases and compact antibodies. The FEBS Journal 276:6, pages 1527-1535.
Crossref
Arthur E. Frankel, Jung-Hee Woo & David M. Neville. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 407 449 .
Christian Menzel, Thomas Schirrmann, Zoltan Konthur, Thomas Jostock & Stefan Dübel. (2008) Human antibody RNase fusion protein targeting CD30+ lymphomas. Blood 111:7, pages 3830-3837.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.